Atlas Trials

High Risk Essential Thrombocythemia

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Risk Essential Thrombocythemia

RecordFirmDate
Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) (NCT01259856)Ronald Hoffman2011-09-01
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) (NCT01259817)Ronald Hoffman2011-09-01

Track High Risk Essential Thrombocythemia automatically

Every clearance here is in the API, with alerts when new ones post.